nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.12.2020 | editorial

Molecular profiling—ready for clinical routine

verfasst von: Assoc. Prof. Armin Gerger, MD, MBA

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

In this special issue of the Magazine of European Medical Oncology (MEMO) multidisciplinary experts summarize and discuss recent developments and future perspectives of comprehensive molecular profiling spanning from specific cancer entities to agnostic approaches [1‐3]. …

Vorheriger Artikel Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed

Nächster Artikel Homologous recombination deficiency in epithelial ovarian cancer

Puhr HC, Ilhan-Mutlu A. Molecular profiling in gastroesophageal cancer—clinical routine and future perspective. memo. 2019;12. https://doi.org/10.1007/s12254-019-00534-7.CrossRef

Tendl KA, Bago-Horvath Z. Molecular profiling in breast cancer—ready for clinical routine?. memo. 2020;13(4). https://doi.org/10.1007/s12254-020-00578-0.CrossRef

Prager G, Gerger A, Höfler G, Webersinke G, Rumpold H, Winder T, Bartsch R, Preusser M, Eisterer W. Position statement of the Austrian Society for Hematology and Medical Oncology on the use of molecular diagnostics in solid tumors. memo 2020;13(4). https://doi.org/10.1007/s12254-020-00662-5.CrossRef

Kato S, Subbiah V, Kurzrock R. Counterpoint: successes in the pursuit of precision medicine: biomarkers take credit. J Natl Compr Canc Netw. 2017;15(7):863–6.CrossRef

Von Hoff DD, Stephenson JJ Jr, Rosen P, et al. Pilot study using molecular profiling of patients’ tumors to find potential targets and select treatments for their refractory cancers. J Clin Oncol. 2010;28(33):4877–83.CrossRef

Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71–88.CrossRef

Westphalen CB, Bokemeyer C, Büttner R, et al. Conceptual framework for precision cancer medicine in Germany: consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy. Eur J Cancer. 2020;135:1–7.CrossRef

Titel: Molecular profiling—ready for clinical routine
verfasst von: Assoc. Prof. Armin Gerger, MD, MBA
Publikationsdatum: 01.12.2020
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 4/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-020-00663-4

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Homologous recombination deficiency in epithelial ovarian cancer

A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed

Molecular profiling in breast cancer—ready for clinical routine?

Established treatment concepts for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSSC)

Fertility preservation in women with endometrial cancer